People · Operator
Named in public records as an officer, director or promoter · active 2014–2022 · Manufacturing, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amyris, Inc. | — | Manufacturing | Series D+ | $1.6B | $77.1M | 2014 |
| Talphera, Inc. | — | Pharmaceuticals | Series B | $97.4M | $74.2M | 2022 |
RAFFI ASADORIAN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside RAFFI ASADORIAN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| JOHN DOERR | 1 | 14 |
| Mark Wan | 1 | 10 |
| Stephen Hoffman | 1 | 7 |
| Howard Rosen | 1 | 5 |
| Geoff Duyk | 1 | 5 |
| Guy Nohra | 1 | 5 |
| Neil Renninger | 1 | 4 |
| Mark Edwards | 1 | 4 |
| Howard B. Rosen | 1 | 4 |
| L. John Doerr | 1 | 4 |
| James Welch | 1 | 4 |
| John Melo | 1 | 3 |
| Marina Bozilenko | 1 | 3 |
| Philippe Boisseau | 1 | 3 |
| Richard King | 1 | 3 |
| Patrick Pichette | 1 | 3 |
| James H. Welch | 1 | 3 |
| GEOFFREY DUYK | 1 | 2 |
| Carole Piwnica | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.